CTRNF yields 1111.11% · MRK yields 2.81%● Live data
📍 CTRNF pulled ahead of the other in Year 1
Combined, CTRNF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CTRNF + MRK for your $10,000?
CHAR Technologies Ltd., a cleantech development and services company, engages in the conversion of organic waste into clean energy and biocarbon products. It offers SulfaCHAR, an activated biochar designed and developed to capture noxious hydrogen sulfide; Cleanfyre, a form of bio coal that allows large industrial users to switch from heavy greenhouse gas (GHG) emission fossil coal to GHG-neutral bio coal; and equipment for industrial water treatment. The company also provides environmental compliance and management, site investigation and remediation, engineering, and resource efficiency services. It serves food and beverage, industrial, and renewable gas project customers. CHAR Technologies Ltd. was founded in 2011 and is headquartered in Toronto, Canada.
Full CTRNF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.